Forschung in Hamburg - © www.mediaserver.hamburg.de/Norgenta
HAW Campus Berliner Tor - © Elke Stagat / HAW Hamburg

Life science firms meet professionals of the future

Company contact day at HAW's Faculty of Life Sciences. International firms on hand for talks

The Faculty of Life Sciences at the Hamburg University of Applied Sciences (HAW) regularly invites firms to meet professionals of the future. The next event, organised by ecotrophologists and health researchers at the university, has been scheduled for April 19, 2016 at HAW’s Bergedorf campus.

Working in the pharmaceutical industry

Municipal institutions such as the Hamburg Authority of Health and Consumer Protection, the Germany-wide Association of Oecotrophologen (VDOE) as well as Johnson & Johnson, the U.S. multinational medical devices, pharmaceutical and consumer packaged goods manufacturer, will be on hand.

The firms can show students possible career opportunities during lectures and individual talks. AstraZeneca, a British-Swedish multinational pharmaceutical company, will describe work in the pharmaceutical industry while the Hamburg-based machine builders, Endress + Hauser Messtechnik will talk about daily work in a technical operation.

Over 16,000 students at HAW

The Hamburg University of Applied Sciences (HAW) is described as “one of the largest practically-oriented universities in the north”. It is a member of the north German Life Science Nord network. The HAW offers a wide range of Bachelor and Master’s programmes in engineering, IT, life sciences, design and media as well as business and social sciences. According to HAW, some 16,642 students are presently enrolled at the university.
pb

Sources and further information:
www.haw-hamburg.de
www.haw-hamburg.de/firmenkontakttag
www.facebook.com/fkt2016
www.lifesciencenord.de

About Life Science Nord

The cluster management Life Science Nord is dedicated to innovative medicine in Hamburg and Schleswig-Holstein. In over 500 biotech/pharma and medical technology companies and several research institutes, 20,000 highly qualified professionals develop innovative medicines, medical products and services. With a complete value chain – from basic and applied research to clinical tests and the market-ready end product – the Life Science Nord cluster offers a unique infrastructure: practically oriented researchers and clinical staff cooperate closely with partners in the industry to help innovative products and technologies make a breakthrough.

The states of Hamburg and Schleswig-Holstein each have a 40 per cent share in the Life Science Nord Management GmbH. Around 200 companies and organisations in biomedicine and related industries have formed the research and industry association Life Science Nord e.V. For more information, see: www.lifesciencenord.de

More articles

  • There are no older articles in this category.
  • There are no newer articles in this category.